Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.1K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Multifunctional efficacy of pyrolignous acid as an antioxidant and biostimulant for enhanced wheat growth.

3 Biotech·2026
Same author

Chondroitin sulfate and chondroitinase ABC: emerging roles in drug delivery and wound healing applications.

Journal of biomaterials science. Polymer edition·2026
Same author

Catalytic carboxylation of sp<sup>2</sup> and sp<sup>3</sup> C-H bonds with CO<sub>2</sub> under atmospheric pressure conditions: an integrated experimental and theoretical study.

Materials horizons·2026
Same author

Engineering cardiac regeneration using stem cells: Cellular sources, differentiation signatures, targeted delivery, and functional recovery.

Regenerative therapy·2026
Same author

Optimization and evaluation of gastro-expandable film of Eudragit S100 and ethylcellulose by using the design of experiment.

Scientific reports·2026
Same author

Enhancing drug synergy in malignant diseases with deep architecture optimization algorithms.

Computer methods in biomechanics and biomedical engineering·2026

相关实验视频

Updated: Jul 26, 2025

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.2K

使用深度学习的恶性疾病的药物协同模式.

Pooja Rani1, Kamlesh Dutta1, Vijay Kumar2

  • 1Department of Computer Science and Engineering, National Institute of Technology, Hamirpur, HP 177005, India.

Journal of bioinformatics and computational biology
|June 23, 2023
PubMed
概括

药物协同作用提供了一个有前途的癌症治疗方法. 一个新的深度学习模型,DrugSymby,有效地预测协同药物组合,克服传统方法的局限性.

关键词:
药物协同作用 药物协同作用深度学习是一种深度学习.药物组合 药物组合 药物组合恶性疾病恶性疾病.神经网络的神经网络的神经网络

更多相关视频

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.8K

相关实验视频

Last Updated: Jul 26, 2025

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.2K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.2K
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
07:46

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments

Published on: April 30, 2021

4.8K

科学领域:

  • 在瘤学瘤学.
  • 计算生物学 计算生物学
  • 人工智能的人工智能

背景情况:

  • 药物协同作用是癌症治疗的关键策略,提高了疗效,降低了毒性.
  • 大量的潜在药物组合使得实验验证具有挑战性.
  • 以前的计算方法忽视了高阶药物组合.

研究的目的:

  • 介绍DrugSymby,这是一个新的深度学习模型,用于预测协同药物组合.
  • 解决识别高阶协同药物组合的局限性.
  • 为了利用人工智能,有效地发现药物组合.

主要方法:

  • 开发了一个深度学习模型DrugSymby.
  • 使用的数据集包括抗癌药物,基因表达特征和细胞系查数据.
  • 在NCI-ALMANAC查数据集上训练和评估模型.

主要成果:

  • 药物Symby实现了高性能,f1得分为0.98,回忆率为0.99,精度为0.98.
  • 模型评估证实了DrugSymby在预测药物组合方面的有效性.
  • 该模型在独立查数据上表现出强大的预测能力.

结论:

  • 药物Symby是预测协同药物组合的有效工具.
  • 该模型增强了对新且有效的抗癌药物组合的探索.
  • 这种方法可以加速发现针对恶性瘤的优化组合疗法.